Newsbenzinga
Pfizer Cancer Therapy Shows Extended Progression-Free Survival in Multiple Myeloma Patients
· Published
Article summary
Pfizer reports positive Phase 3 ELREXFIO data showing reduced disease progression risk in relapsed or refractory multiple myeloma patients.
An excerpt from the original article.
Comments —
Loading comments…